Items where authors include "Calvi, A."

Article

John, N.A., Li, Y., De Angelis, F. et al. (47 more authors) (2026) Vascular Comorbidities and an Increased Comorbidity Score Are Associated With Disability and Disability Progression in Secondary Progressive Multiple Sclerosis. European Journal of Neurology, 33 (2). e70517. ISSN 1351-5101

Chataway, J., Williams, T., Blackstone, J. et al. (135 more authors) (2025) Effect of repurposed simvastatin on disability progression in secondary progressive multiple sclerosis (MS-STAT2): a phase 3, randomised, double-blind, placebo-controlled trial. The Lancet, 406 (10512). pp. 1611-1624. ISSN 0140-6736

De Angelis, F., Cameron, J.R., Eshaghi, A. et al. (14 more authors) (2025) Optical coherence tomography in secondary progressive multiple sclerosis: cross-sectional and longitudinal exploratory analysis from the MS-SMART randomised controlled trial. Journal of Neurology, Neurosurgery and Psychiatry, 96 (7). pp. 647-654. ISSN 0022-3050

Blackstone, J., Williams, T., Nicholas, J.M. et al. (59 more authors) (2024) Evaluating the effectiveness of simvastatin in slowing the progression of disability in secondary progressive multiple sclerosis (MS-STAT2): protocol for a multicentre, randomised controlled, double-blind, phase 3 clinical trial in the UK. BMJ Open, 14 (9). e086414. ISSN 2044-6055

John, N., Li, Y., De Angelis, F. et al. (49 more authors) (2024) Brain reserve and physical disability in secondary progressive multiple sclerosis. BMJ Neurology Open, 6 (2). e000670. ISSN 2632-6140

Williams, T., John, N., Calvi, A. et al. (18 more authors) (2023) Cardiovascular risk factors in secondary progressive multiple sclerosis: A cross‐sectional analysis from the MS‐STAT2 randomized controlled trial. European Journal of Neurology, 30 (9). pp. 2769-2780. ISSN 1351-5101